ArticleWorld journal of gastroenterology2026
Percutaneous
Article in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHydatid cyst disease of the liver remains a significant public health problem in endemic regions. While surgical treatment has traditionally been the mainstay of therapy, minimally invasive percutaneous approaches have emerged as safe and effective alternatives, especially for selected World Health Organization (WHO) cystic echinococcosis (CE) 1 and CE3a cysts. Comparative data on efficacy, complication rates, and clinical outcomes between the two methods are essential for guiding optimal treatment selection.
aimTo compare and evaluate the efficacy, safety, complication rates, and clinical course of WHO CE1 and CE3a liver hydatid cysts treated with surgical and percutaneous methods.
methodsA total of 989 patients diagnosed with liver hydatid cyst and treated either surgically (
resultsThere was no significant difference between the surgical (
conclusionFor treatment of WHO CE1 and CE3a liver cysts, the percutaneous approach is a safe and effective method due to shorter hospital stays, minimal invasiveness, and negligible risk of intraoperative organ injury, whereas surgical methods appear marginally advantageous regarding recollection and anaphylaxis. In both groups, higher cyst volume increases the risk of fistula and may prolong the treatment process. Patient selection should consider these parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.